Alcon previews water-gradient contact lens

Article

During the 90th annual SECO International meeting, Erich Bauman, OD, FAAO, Alcon’s program head of vision care R&D, shared information about Dailies Total 1, the company’s new contact lens set to launch later this year.

During a media briefing at the 90th annual SECO International meeting in Atlanta, Erich Bauman, OD, FAAO, Alcon’s program head of vision care R&D, shared information about the company’s new contact lens to launch later this year.

Dailies Total 1 (delefilcon A) combines advanced surface chemistry, new silicone hydrogel lens material, and next-generation LightStream Lens technology to create a new platform of water-gradient contact lenses.

The lens features a gradual transition from 33% water at its core to more than 80% water content at its surface, mimicking the water content of the cornea. It has very high surface lubricity and oxygen transmissibility, both of which provide exceptional comfort lasting all day, said Dr. Bauman.

The lens core has a low water content, high oxygen transmissibility, and a low modulus. The lens surface is an ultrasoft surface gel, which is 6 µm thick.

“Dailies Total 1 offers the properties of silicone hydrogel with a surface containing no silicone,” said Dr. Bauman.

Dailies Total 1 will launch with minus power availability in the U.S. later this year; it has already launched in some European countries and will launch in the U.K. next week.

The company plans to expand water-gradient contact lenses into a full line of lens offerings, including plus powers, toric, and multifocal. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.